# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-062203
Filing Date
2023-11-09
Accepted
2023-11-09 17:00:32
Documents
65
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | eldn-20230930.htm iXBRL | 10-Q | 2048570
2 | EX-31.1 | eldn-ex31_1.htm | EX-31.1 | 16313
3 | EX-31.2 | eldn-ex31_2.htm | EX-31.2 | 16647
4 | EX-32.1 | eldn-ex32_1.htm | EX-32.1 | 10784
5 | EX-32.2 | eldn-ex32_2.htm | EX-32.2 | 10965
| Complete submission text file | 0000950170-23-062203.txt |  | 7118421

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | eldn-20230930_pre.xml | EX-101.PRE | 279243
7 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | eldn-20230930.xsd | EX-101.SCH | 53110
8 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | eldn-20230930_lab.xml | EX-101.LAB | 360807
9 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | eldn-20230930_def.xml | EX-101.DEF | 179469
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | eldn-20230930_cal.xml | EX-101.CAL | 34946
59 | EXTRACTED XBRL INSTANCE DOCUMENT | eldn-20230930_htm.xml | XML | 1189178

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36620 | Film No.: 231393545
SIC: 2834 Pharmaceutical Preparations